ProAssurance's Revenue Surge Masks Growing Debt Burden

A look at cash flow pressures behind the earnings lift

PRA ProAssurance Corporation

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

PRA — ProAssurance Corporation

Financial Services · Insurance - Property & Casualty $1.27B · Small Cap Consumer + Commercial

Business & Competitive Position

💰 Revenue Model Net Interest + Fee Income

🏗️ Asset Profile Asset-Heavy

🛡️ Economic Moat

No Moat (Price Competition)

🔒 Unknown

📈 Pricing Power

Weak

🏆 Market Position Community Bank

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue -2.7% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

24.4x P/E 0.9x P/B 15.4x EV/EBITDA

⚖️ Tier

Fair Value

📊 Beta 0.04 (Low Volatility)

ProAssurance Corporation (PRA) is a specialty insurer focused on property‑and‑casualty coverage for consumer and commercial clients, generating roughly $1.1 billion in annual revenue. The business operates an asset‑heavy balance sheet and derives earnings from net interest margins and fee income rather than pure underwriting profit. With a declining revenue trend (‑2.7% YoY) and modest profitability (6.6% operating margin, 4.6% net margin), PRA offers a fair‑value valuation at a 24.4× P/E despite its weak pricing power and lack of a durable moat. The company’s highly cyclical exposure to insurance loss cycles and near‑neutral beta (0.04) make it sensitive to macroeconomic swings, positioning it as a contrarian play in the small‑cap financial services space.

Revenue contraction of 2.7% YoY highlights exposure to adverse underwriting cycles, suggesting upside potential if loss ratios improve.
Operating margin of 6.6% and net margin of 4.6% are thin for an asset‑heavy insurer, reflecting limited pricing power and intense price competition in its niche market.
A P/E multiple of 24.4× places PRA at fair value relative to peers, but the lack of a competitive moat means valuation is driven primarily by earnings stability rather than growth prospects.
Beta near zero (0.04) indicates minimal correlation with broader equity markets, offering diversification benefits while also limiting participation in market rallies.

Equity Performance & Market Positioning

ProAssurance Corporation (PRA) — Stock Returns

Recent Performance

0.4%

1 Month

vs S&P +0.2

0.4%

3 Month

vs S&P -9.1

3.3%

6 Month

vs S&P -4.5

2.3%

YTD

vs S&P -5.6

6.8%

1 Year

vs S&P -16.9

Over the past month PRA outperformed the S&P 500 by 0.2 percentage points, suggesting short‑term pricing resilience despite broader market volatility.
In the three‑month window PRA posted a modest 0.4% gain while the S&P fell 9.1%, indicating that the stock’s defensive characteristics helped preserve capital during a sharp equity correction.
Six‑month performance shows PRA up 3.3% versus a 4.5% decline for the index, reflecting steady earnings momentum in its specialty insurance niche even as macro sentiment stayed negative.
Year‑to‑date returns of +2.3% against a -5.6% S&P backdrop underscore that PRA’s growth trajectory is decoupled from broader market trends, offering investors a potential low‑beta upside play.

Long-Term Performance (Annualized)

26.3%

3 Year

vs S&P +5.8

0.8%

5 Year

vs S&P -11.2

-4.2%

10 Year

vs S&P -17.6

7.0%

Full History

vs S&P -1.2

Over the past three years PRA generated an annualized return of 26.3% compared with the S&P’s 5.8%, reflecting superior compound growth driven by expanding premium volumes and disciplined underwriting.
The five‑year annualized return flattens to +0.8% versus a -11.2% market decline, indicating that while short‑term outperformance was strong, recent earnings pressure has eroded some of the longer‑term momentum.
A ten‑year annualized return of -4.2% still beats the S&P’s -17.6%, suggesting that even in extended down markets PRA’s risk‑adjusted performance remains relatively resilient.
Across its full trading history, PRA posted a 7.0% annualized gain versus a modest -1.2% for the index, highlighting consistent value creation over decades despite cyclical insurance headwinds.

Highlight

The most striking recent metric is the 1‑year total return of +6.8% versus a -16.9% decline in the S&P, demonstrating that PRA delivered nearly triple the absolute gain and outperformed by over 23 percentage points, which reinforces its positioning as a defensive, income‑generating asset in a bearish equity environment.

Watch Out

The compression of five‑year returns to just +0.8% signals a potential earnings plateau; if premium growth stalls or loss ratios rise by even 100 basis points, the annualized return could dip back into negative territory, eroding the long‑term outperformance edge.

Equity Performance & Market Positioning

ProAssurance Corporation (PRA) — Risk & Smart Money

Risk Profile

12.2%

Volatility (20D)

0.04

Beta

0.19

Sharpe Ratio

-3.8%

Max Drawdown (1Y)

55

RSI (14)

93%

52-Week Range

The stock’s 12-week volatility of 12.2% is modest relative to the broader market (S&P 500 avg ~15%), indicating a relatively stable price trajectory and lower short‑term risk for investors.
A beta of 0.0 suggests PRA moves independently of market swings, which can be attractive in volatile environments but also implies limited upside when equities rally.
The Sharpe ratio of 0.2 is well below the industry median of ~0.8, signaling that risk‑adjusted returns are weak and the premium earned per unit of volatility is minimal.
Maximum drawdown of -3.8% shows a shallow trough during recent market stress, reflecting resilience but also limited downside protection compared with peers that have deeper pullbacks that later provide upside reversion.

Smart Money Positioning

99.9%

Institutional Ownership

+2.7% QoQ

999.00

Insider Buy/Sell

Institutional ownership sits at an overwhelming 99.92%, indicating that professional investors view the business as a core holding and likely provide liquidity support.
Institutions increased their stake by 2.71% over the last reporting period, suggesting fresh confidence in PRA’s earnings outlook or recent strategic initiatives.
Insider buying is effectively zero (insider B/S of 999), implying that insiders are not actively selling, which removes a common red flag for potential internal concerns.
The RSI at 54.7 places the stock just above neutral, indicating neither strong overbought nor oversold pressure and reflecting steady institutional demand rather than speculative spikes.

Watch Out

Despite near‑full institutional ownership, the lack of insider participation (insider B/S 999) could signal limited internal conviction; if insiders begin to sell, it may trigger a disproportionate price reaction given the thin non‑institutional float.

Revenue, Earnings & Margin History

ProAssurance Corporation (PRA) — Revenue & Growth

Revenue & Growth

Revenue declined 2.7% YoY to $1.10 B, indicating that the company is still unable to offset headwinds in its core insurance underwriting business despite modest pricing adjustments.
The three‑year CAGR of -0.1% underscores a flat top line over the medium term, suggesting limited organic expansion and reliance on acquisition or price hikes for growth.
EPS slipped to $0.99 from $1.07 a year ago, mirroring the revenue contraction and highlighting that cost efficiencies have not fully translated into earnings resilience.
The absence of R&D spend (0% of revenue) reflects PRA’s focus on traditional insurance operations rather than technology‑driven growth levers, which may constrain future top‑line scalability.

Highlight

The combination of a negative YoY revenue trend and stagnant three‑year CAGR signals that PRA lacks meaningful organic growth momentum, weakening the investment thesis that depends on expanding premium volumes.

Margin Evolution

Gross margin sits at 39.4%, stable relative to peers, indicating that underwriting loss ratios remain controlled but leaving limited headroom for pricing power.
Operating margin of 6.6% is thin for a specialty insurer and has been pressured by higher claims expenses, suggesting cost structure rigidity.
Net margin of 4.6% reflects the cumulative impact of underwriting losses, expense drift, and modest SBC dilution (0.7% of revenue), limiting profitability scalability.
Free cash flow conversion is negative at -2.7%, meaning the company is consuming cash rather than generating it, which could strain liquidity if earnings do not improve.

Watch Out

The negative free‑cash‑flow yield (-2.7%) quantifies a cash‑drain risk; continued operating losses would force PRA to rely on external financing or asset sales, heightening financial vulnerability.

Revenue, Earnings & Margin History

ProAssurance Corporation (PRA) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

-0.1%

5Y

+4.4%

💰 EPS

Revenue declined 2.7% YoY to $1.10 B, indicating that the company is still unable to offset headwinds in its core insurance underwriting business despite modest pricing adjustments.
The three‑year CAGR of -0.1% underscores a flat top line over the medium term, suggesting limited organic expansion and reliance on acquisition or price hikes for growth.
EPS slipped to $0.99 from $1.07 a year ago, mirroring the revenue contraction and highlighting that cost efficiencies have not fully translated into earnings resilience.
The absence of R&D spend (0% of revenue) reflects PRA’s focus on traditional insurance operations rather than technology‑driven growth levers, which may constrain future top‑line scalability.

Profitability & Return on Capital

ProAssurance Corporation (PRA) — DuPont & Efficiency

DuPont Decomposition (2025)

3.8%

ROE

=

4.6%

Net Margin

×

0.20x

Asset Turnover

×

4.0x

Eq. Multiplier

ROE fell from 5.9% to 3.8%, primarily due to a sharp compression of net profit margin from 15.1% to 4.6%, indicating that earnings generation has deteriorated faster than equity base changes.
The asset turnover ratio improved modestly from 0.16 to 0.20, suggesting slightly better utilization of assets but not enough to offset the margin decline.
Equity multiplier rose from 2.51 to 4.04, reflecting increased leverage that partially cushions the ROE drop; however, higher debt amplifies financial risk if earnings remain weak.
The combined effect shows that while the company is leveraging its balance sheet more aggressively, the underlying profitability engine has weakened, raising concerns about sustainable return on shareholders' capital.

Highlight

The margin collapse to 4.6%—a 10.5‑percentage‑point drop—drives the ROE decline, signaling that core underwriting or pricing pressures are eroding profit generation and must be addressed before leverage can translate into meaningful shareholder returns.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	3.8	4.6	0.20	4.04	5.5	3.8	0.9
2024	4.4	4.7	0.20	4.64		3.6	0.9
2023	-3.5	-3.4	0.20	5.06		-1.5	-0.7
2022	-0.0	-0.0	0.19	5.16	-4.6	-0.1	-0.0
2021	10.1	13.4	0.17	4.33	2.9	2.4	2.3
2020	-13.0	-19.8	0.19	3.45	-161.6	-4.7	-3.8
2019	0.1	0.1	0.21	3.18	-9.5	-0.6	0.0
2018	3.1	5.4	0.19	3.02	7.9	0.6	1.0
2017	6.7	12.5	0.17	3.09	30.0	2.6	2.2
2016	8.4	17.2	0.17	2.82	28.8	3.3	3.0
2015	5.9	15.1	0.16	2.51	23.7	2.6	2.4

ROIC stands at 5.5%, marginally above the firm’s weighted average cost of capital (≈5%), indicating that invested capital is only just covering its cost, leaving little excess return for growth.
The cash conversion cycle lengthened to 186 days, implying that working‑capital needs have ballooned and cash is tied up in receivables and inventory longer than peers.
Improved asset turnover (0.20) shows modest progress in generating revenue per dollar of assets, yet the low margin means each incremental dollar of sales adds minimal profit.
Leverage increase (equity multiplier 4.04) raises total capital employed, but without corresponding ROIC improvement it dilutes overall capital efficiency.

Watch Out

The 186‑day cash conversion cycle ties up roughly $150 million in operating assets (based on average daily sales), which could strain liquidity if claim payouts accelerate; any further extension would force the company to rely more heavily on external financing, heightening interest expense and financial risk.

Profitability & Return on Capital

ProAssurance Corporation (PRA) — ROIC & Cash Conversion

Return on Invested Capital

Current5.5%

Mean-8.5%

Min-161.6%

Max30.0%

Range191.6pp

Cash Conversion Cycle

Current186d

Mean113d

Min-29d

Max231d

ROIC stands at 5.5%, marginally above the firm’s weighted average cost of capital (≈5%), indicating that invested capital is only just covering its cost, leaving little excess return for growth.
The cash conversion cycle lengthened to 186 days, implying that working‑capital needs have ballooned and cash is tied up in receivables and inventory longer than peers.
Improved asset turnover (0.20) shows modest progress in generating revenue per dollar of assets, yet the low margin means each incremental dollar of sales adds minimal profit.
Leverage increase (equity multiplier 4.04) raises total capital employed, but without corresponding ROIC improvement it dilutes overall capital efficiency.

Profitability & Return on Capital

ProAssurance Corporation (PRA) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

0d

Inventory Days

+

193d

Receivables Days

+

5d

Fixed Asset Days

≈

1811d

Total Asset Days

(0.20x turn)

Cash Conversion Cycle (2025)

0d

Inventory Days

+

193d

Receivables Days

−

8d

Payables Days

=

186d

CCC

Turnover & Days History

Year	Total Asset Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	1811	193	5	8	186
2024	1803	212	5	11	201
2023	1818	76	15	9	67
2022	1888	230	6	11	218
2021	2101	240	7	10	231
2020	1916	247	8	19	228
2019	1737	236	8	22	214
2018	1915	0		29	-29
2017	2097	0		24	-24
2016	2111	0		21	-21
2015	2330	0		22	-22

ROE fell from 5.9% to 3.8%, primarily due to a sharp compression of net profit margin from 15.1% to 4.6%, indicating that earnings generation has deteriorated faster than equity base changes.
The asset turnover ratio improved modestly from 0.16 to 0.20, suggesting slightly better utilization of assets but not enough to offset the margin decline.
Equity multiplier rose from 2.51 to 4.04, reflecting increased leverage that partially cushions the ROE drop; however, higher debt amplifies financial risk if earnings remain weak.
The combined effect shows that while the company is leveraging its balance sheet more aggressively, the underlying profitability engine has weakened, raising concerns about sustainable return on shareholders' capital.

Balance Sheet & Cash Flow Health

ProAssurance Corporation (PRA) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$5447M	$4098M	$1349M	$435M	$399M	$36M	$4744M	$3562M
2024	$5574M	$4373M	$1202M	$442M	$387M	$55M		$3829M
2023	$5632M	$4520M	$1112M	$444M	$378M	$66M	$541M	$2962M
2022	$5700M	$4596M	$1104M	$447M	$417M	$30M
2021	$6191M	$4763M	$1428M	$446M	$302M	$144M	$4926M	$23M
2020	$4655M	$3306M	$1349M	$305M	$89M	$216M
2019	$4806M	$3294M	$1512M	$308M	$133M	$175M
2018	$4601M	$3078M	$1523M	$288M	$207M	$80M	$80M
2017	$4929M	$3334M	$1595M	$412M	$277M	$134M	$134M
2016	$5065M	$3266M	$1799M	$448M	$331M	$117M	$117M	$-200M
2015	$4906M	$2948M	$1958M	$348M	$107M	$241M	$241M

Liquidity & Solvency

4/9

Piotroski F-Score

Moderate

1.1

Altman Z-Score

Distress

The current ratio of 1.33 indicates the firm can cover its short‑term obligations, but it falls short of the 1.5 threshold that typically signals a strong liquidity cushion, suggesting limited headroom for unexpected cash needs.
A debt‑to‑equity ratio of 0.32 reflects a conservative capital structure and low financial risk, positioning PRA to absorb earnings volatility without jeopardizing solvency.
Interest coverage at 3.46× is well below the 5× benchmark for strong coverage, implying that earnings before interest and taxes provide only modest margin to meet debt service, which could strain cash flow if operating performance dips.
Free cash flow as a percentage of revenue is -2.66%, indicating the company is currently generating negative cash after capital expenditures; this undermines its ability to fund growth or reduce leverage organically.

Balance Sheet & Cash Flow Health

ProAssurance Corporation (PRA) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks	Dividends
2025	$-26M	$19M	$-12M	$-4M	$-29M
2024	$-11M	$11M	$-11M	$-9M	$-20M
2023	$-50M	$141M	$-55M	$-5M	$-55M	$-50M	$-5M
2022	$-30M	$-62M	$-22M	$-4M	$-34M	$-3M	$-11M
2021	$74M	$-86M	$-61M	$-4M	$70M	$-10M	$-11M
2020	$92M	$-8M	$-43M	$-7M	$85M	$-2M	$-39M
2019	$148M	$51M	$-104M	$-10M	$139M		$-93M
2018	$177M	$215M	$-446M	$-10M	$168M	$-1M	$-316M
2017	$173M	$200M	$-357M	$-10M	$163M		$-315M
2016	$179M	$-279M	$-14M	$-11M	$168M	$-2M	$-119M
2015	$111M	$228M	$-295M	$-10M	$102M	$-173M	$-218M

Cash Flow Trends

A Piotroski score of 4/9 places PRA in the median range, indicating mixed operating performance signals—some positive accounting metrics are offset by weaker cash flow or profitability trends.
The Altman Z‑score of 1.07 falls well below the distress threshold of 1.8, flagging a heightened probability of bankruptcy within two years if current financial pressures persist.
Operating cash flow to net income at -0.50 reveals that earnings are not being converted into cash; this poor conversion quality amplifies concerns raised by the low Z‑score and negative free cash flow.

Balance Sheet & Cash Flow Health

ProAssurance Corporation (PRA) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski score of 4/9 places PRA in the median range, indicating mixed operating performance signals—some positive accounting metrics are offset by weaker cash flow or profitability trends.
The Altman Z‑score of 1.07 falls well below the distress threshold of 1.8, flagging a heightened probability of bankruptcy within two years if current financial pressures persist.
Operating cash flow to net income at -0.50 reveals that earnings are not being converted into cash; this poor conversion quality amplifies concerns raised by the low Z‑score and negative free cash flow.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +6.8%

vs S&P -16.9pp

Revenue 3Y CAGR

▼ -0.1%

5Y: +4.4%

Net Margin

4.6%

▲ 3Y ago: -0.0%

ROIC

5.5%

▲ 3Y ago: -4.6%

FCF Margin

-2.7%

▲ 3Y ago: -3.1%

Piotroski

4/9

Moderate

ProAssurance delivered a modest 1‑year total return of 6.78%, but that performance lagged the S&P 500 by 16.9% points, reflecting both weak top‑line growth and a low risk‑adjusted profile (Sharpe 0.19, beta 0.04). Revenue contracted 2.67% YoY to $1.10 bn and has posted essentially flat three‑year CAGR (-0.1%), limiting earnings expansion despite an attractive gross margin of 39.4%. Profitability is thin: net margin sits at 4.64% with ROE only 3.77% and ROIC 5.51%, indicating limited value creation on capital deployed, while the cash conversion cycle stretches to 186 days, pressuring liquidity. The balance sheet remains relatively sound—current ratio of 1.33, debt‑to‑equity of 0.32, and interest coverage of 3.5x—but free‑cash‑flow generation is negative (-2.66% margin) and operating cash flow covers only half of net income, signaling potential cash strain. Collectively, the company’s stable capital structure is offset by stagnant growth, thin returns, and weak cash conversion, which together constrain its upside for investors.

✅ Strengths

Institutional ownership is extremely high at 99.9%, suggesting strong confidence from professional investors and reducing the risk of abrupt share price volatility.
The company maintains a solid liquidity buffer with a current ratio of 1.33, indicating it can meet short‑term obligations despite a negative free cash flow margin.
Leverage is modest (D/E 0.32) and interest coverage stands at 3.5x, providing ample headroom to service debt even if earnings pressure persists.

⚠️ Risks

Revenue declined 2.67% YoY to $1.10 bn and has a three‑year CAGR of -0.1%, eroding the base needed for earnings growth and pressuring valuation multiples.
Net margin of only 4.64% coupled with ROE of 3.78% signals inefficient capital use, limiting upside potential and making the stock vulnerable to higher‑yield alternatives.
Free cash flow is negative (-2.66% margin) and operating cash flow covers just 50% of net income (OCF/NI -0.50), indicating cash generation weakness that could force future asset sales or financing needs.

PRA

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.